Back

Cost-of-illness analysis of long-term healthcare resource utilization and disease burden in patients with pulmonary embolism: insights from the PREFER in VTE registry

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Acute pulmonary embolism: aftermath Pulmonary Embolism (PE) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Ioannis Farmakis

Ludwig Maximilians University, Munich (Germany)

5 More presentations in this session

Presentation thumbnail
Predictors of acute pulmonary embolism-related hospitalizations - an artificial neural network analysis using a nationwide cohort in the United States
Doctor J. Verma (Sangrur, IN)
Abstract Slides Video
Presentation thumbnail
Two-year quality of life after acute pulmonary embolism: results from the FOCUS study
Miss A. Mavromanoli (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Causes of death and predictors of long-term mortality after pulmonary embolism
Doctor M. Ebner (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Signs of chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: results from the FOCUS study
Doctor S. Barco (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Chronic thromboembolic pulmonary hypertension and mortality after venous thromboembolism: a nationwide population-based cohort study
Mr K. Bonnesen (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Acute pulmonary embolism: aftermath

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Direct annual healthcare costs in survivors of acute pulmonary embolism: estimates based on a prospective multicentre cohort study
thumbnail
Congress Presentation
Burden and long-term impact of pulmonary embolism on health-related quality of life: a matched cohort study
thumbnail
Congress Presentation
Extracranial bleeding in patients with acute pulmonary embolism: a german nationwide inpatient sample analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources